Research / ZS / Fundamental state Inspectable configuration
State dimensions Filing 0001713683-22-000056 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
332.83% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 79th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.capex_revenue_ratio
9.62% · OPTIONAL · VALID
Operating cash generation 71th Own-history percentile · N=14
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
26.93% · OPTIONAL · VALID
Revenue growth 92th Own-history percentile · N=12
Evidence method Yoy · gp.fundamentals.revenue
62.59% · CORE · VALID
Gross margin 19th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.gross_margin
77.68% · CORE · VALID
Operating margin 25th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.operating_margin
-30.19% · CORE · VALID
R&D intensity 88th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
26.70% · OPTIONAL · VALID
SBC intensity 69th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
36.91% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 7/8 normalized Level 3 Jan 31, 2022 5/6 normalized Level 3 Apr 30, 2022 7/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 31, 2022 8/8 normalized Level 3 Jan 31, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 31, 2023 8/8 normalized Level 3 Oct 31, 2023 8/8 normalized Level 3 Jan 31, 2024 6/6 normalized Level 3 Apr 30, 2024 8/8 normalized Level 3 Jul 31, 2024 8/8 normalized Level 3 Oct 31, 2024 8/8 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 8/8 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 368.09%
Current 332.83%
Delta -35.26% Growth Decreased
Previous 62.73%
Current 62.59%
Delta -0.15% Margin Increased
Previous 77.39%
Current 77.68%
Delta 0.29% Profitability Increased
Previous -32.84%
Current -30.19%
Delta 2.65% R And D Intensity Decreased
Previous 27.08%
Current 26.70%
Delta -0.38% Sbc Intensity Decreased
Previous 38.73%
Current 36.91%
Delta -1.83% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.